Regeneron Pharmaceuticals, Inc. Stock price
Equities
REGN
US75886F1075
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
962.5 USD | -0.39% | -0.57% | +9.59% |
Mar. 25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
Mar. 25 | Regeneron Shares Down After FDA Letter Questioning Application for Potential Lymphoma Treatment | MT |
Financials (USD)
Sales 2024 * | 13.89B | Sales 2025 * | 14.91B | Capitalization | 103B |
---|---|---|---|---|---|
Net income 2024 * | 4.26B | Net income 2025 * | 4.54B | EV / Sales 2024 * | 6.81 x |
Net cash position 2024 * | 8.91B | Net cash position 2025 * | 12.78B | EV / Sales 2025 * | 6.08 x |
P/E ratio 2024 * |
26.4
x | P/E ratio 2025 * |
24.7
x | Employees | 13,450 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.74% |
Latest transcript on Regeneron Pharmaceuticals, Inc.
1 day | -0.39% | ||
1 week | -0.57% | ||
Current month | -0.37% | ||
1 month | -2.54% | ||
3 months | +9.16% | ||
6 months | +15.33% | ||
Current year | +9.59% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 64 | 88-01-07 | |
Chief Executive Officer | 71 | 88-01-07 | |
Director of Finance/CFO | 54 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christine Poon
BRD | Director/Board Member | 71 | 10-11-11 |
Chief Executive Officer | 71 | 88-01-07 | |
Michael Brown
BRD | Director/Board Member | 82 | 91-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.27% | 0 M€ | 0.00% | - | |
7.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 962.5 | -0.39% | 461,867 |
24-03-27 | 966.3 | +0.29% | 314,755 |
24-03-26 | 963.6 | +0.26% | 386,837 |
24-03-25 | 961.1 | -0.64% | 322,288 |
24-03-22 | 967.2 | -0.08% | 274,406 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.59% | 103B | |
+2.73% | 108B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B | |
-6.78% | 10.2B |